Therapeutic use of a thienylcyclohexylamine derivative

   
   

A method of inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals comprising administering to warm-blooded animals before exposure to said products an inhibitorily effective amount of reversible cholinesterase inhibitor selected from the group consisting of pyridostigmine and physostigmine followed by administration of an inhibitorily effective amount of 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in substantially pure racemic, diastereoisomeric or enantiomeric form.

Метод блокируя влияний экзогенных neurotoxic или neurotoxinic продуктов в warm-blooded животных состоя из administering к warm-blooded животным перед подвержением к сказанным продуктам inhibitorily эффективное, котор количество реверзибельного иа АБС битор холинэстеразы выбрало от pyridostigmine группы consist of и физостигмин последовал за администрацией inhibitorily эффективного количества 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane в существенн чисто рацемической, diastereoisomeric или enantiomeric форме.

 
Web www.patentalert.com

< 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase

< 8-carboxamido-2,6-methano-3-benzazocines

> Pyrazole compositions useful as inhibitors of ERK

> Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents

~ 00129